Seres Therapeutics, Inc. MCRB
$2.15
+2.88%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 10-Q | 10-Q | 2026-11-04 | View → |
| 8-K | 8-K | 2026-11-04 | View → |
| 8-K | 8-K | 2026-10-26 | View → |
| 4 | 4 | 2026-08-18 | View → |
| 4 | 4 | 2026-08-18 | View → |
| 4 | 4 | 2026-08-18 | View → |
| 4 | 4 | 2026-08-18 | View → |
| S-3 | S-3 | 2026-08-13 | View → |
| 10-Q | 10-Q | 2026-08-05 | View → |
| 8-K | 8-K | 2026-08-05 | View → |
| 8-K | 8-K | 2026-08-04 | View → |
| 424B5 | 424B5 | 2026-08-04 | View → |
| 4 | 4 | 2026-07-10 | View → |
| 4 | 4 | 2026-07-10 | View → |
| 4 | 4 | 2026-07-10 | View → |
| 4 | 4 | 2026-07-10 | View → |
| 4 | 4 | 2026-07-10 | View → |
| 4 | 4 | 2026-07-10 | View → |
| 4 | 4 | 2026-07-10 | View → |
| 4 | 4 | 2026-07-10 | View → |
| 4 | 4 | 2026-07-10 | View → |
| 4 | 4 | 2026-07-10 | View → |
| 4 | 4 | 2026-07-10 | View → |
| 4 | 4 | 2026-07-10 | View → |
| 8-K | 8-K | 2026-07-08 | View → |
| 8-K | 8-K | 2026-07-08 | View → |
| 4 | 4 | 2026-07-02 | View → |
| 4 | 4 | 2026-07-02 | View → |
| 4 | 4 | 2026-07-02 | View → |
| 8-K | 8-K | 2026-06-05 | View → |
| 8-K | 8-K | 2026-06-01 | View → |
| 4 | 4 | 2026-05-19 | View → |
| 4 | 4 | 2026-05-19 | View → |
| 4 | 4 | 2026-05-19 | View → |
| 4 | 4 | 2026-05-19 | View → |
| 10-Q | 10-Q | 2026-05-05 | View → |
| 8-K | 8-K | 2026-05-05 | View → |
| DEF 14A | DEF 14A | 2026-04-27 | View → |
| 8-K | 8-K | 2026-03-16 | View → |
| 10-K | 10-K | 2026-03-12 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $2.15
- Market Cap
- $21.31 million
- 52-Week Range
- $1.68 – $29.98
- Average Volume
- 79K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.